Citius Oncology (NASDAQ:CTOR) reported its Q1 earnings results on Friday, February 13, 2026 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Citius Oncology missed estimated earnings by -50.0%, reporting an EPS of $-0.06 versus an estimate of $-0.04.

Revenue was up $3.94 million from the same period last year.

Earnings History Overview

Last quarter the company missed on EPS by $0.0 which was followed by a 9.84% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Citius Oncology visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.